S&P 500   3,769.96 (-2.07%)
DOW   30,433.44 (-1.63%)
QQQ   321.13 (-2.27%)
AAPL   142.55 (-0.43%)
MSFT   232.36 (+0.01%)
FB   273.28 (-3.11%)
GOOGL   1,821.35 (-4.54%)
AMZN   3,251.36 (-2.25%)
TSLA   875.40 (-0.87%)
NVDA   517.02 (-3.79%)
BABA   262.00 (-1.47%)
CGC   38.19 (+7.52%)
GE   10.76 (-4.69%)
MU   75.68 (-4.82%)
AMD   89.29 (-5.72%)
NIO   57.32 (-4.96%)
T   29.08 (-2.25%)
F   10.79 (-3.57%)
ACB   11.41 (+6.94%)
BA   192.94 (-4.51%)
DIS   163.06 (-3.83%)
NFLX   533.00 (-5.15%)
GILD   65.59 (-1.66%)
S&P 500   3,769.96 (-2.07%)
DOW   30,433.44 (-1.63%)
QQQ   321.13 (-2.27%)
AAPL   142.55 (-0.43%)
MSFT   232.36 (+0.01%)
FB   273.28 (-3.11%)
GOOGL   1,821.35 (-4.54%)
AMZN   3,251.36 (-2.25%)
TSLA   875.40 (-0.87%)
NVDA   517.02 (-3.79%)
BABA   262.00 (-1.47%)
CGC   38.19 (+7.52%)
GE   10.76 (-4.69%)
MU   75.68 (-4.82%)
AMD   89.29 (-5.72%)
NIO   57.32 (-4.96%)
T   29.08 (-2.25%)
F   10.79 (-3.57%)
ACB   11.41 (+6.94%)
BA   192.94 (-4.51%)
DIS   163.06 (-3.83%)
NFLX   533.00 (-5.15%)
GILD   65.59 (-1.66%)
S&P 500   3,769.96 (-2.07%)
DOW   30,433.44 (-1.63%)
QQQ   321.13 (-2.27%)
AAPL   142.55 (-0.43%)
MSFT   232.36 (+0.01%)
FB   273.28 (-3.11%)
GOOGL   1,821.35 (-4.54%)
AMZN   3,251.36 (-2.25%)
TSLA   875.40 (-0.87%)
NVDA   517.02 (-3.79%)
BABA   262.00 (-1.47%)
CGC   38.19 (+7.52%)
GE   10.76 (-4.69%)
MU   75.68 (-4.82%)
AMD   89.29 (-5.72%)
NIO   57.32 (-4.96%)
T   29.08 (-2.25%)
F   10.79 (-3.57%)
ACB   11.41 (+6.94%)
BA   192.94 (-4.51%)
DIS   163.06 (-3.83%)
NFLX   533.00 (-5.15%)
GILD   65.59 (-1.66%)
S&P 500   3,769.96 (-2.07%)
DOW   30,433.44 (-1.63%)
QQQ   321.13 (-2.27%)
AAPL   142.55 (-0.43%)
MSFT   232.36 (+0.01%)
FB   273.28 (-3.11%)
GOOGL   1,821.35 (-4.54%)
AMZN   3,251.36 (-2.25%)
TSLA   875.40 (-0.87%)
NVDA   517.02 (-3.79%)
BABA   262.00 (-1.47%)
CGC   38.19 (+7.52%)
GE   10.76 (-4.69%)
MU   75.68 (-4.82%)
AMD   89.29 (-5.72%)
NIO   57.32 (-4.96%)
T   29.08 (-2.25%)
F   10.79 (-3.57%)
ACB   11.41 (+6.94%)
BA   192.94 (-4.51%)
DIS   163.06 (-3.83%)
NFLX   533.00 (-5.15%)
GILD   65.59 (-1.66%)
Log in
OTCMKTS:EMHTF

Emerald Health Therapeutics Stock Forecast, Price & News

$0.18
0.00 (0.00 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.17
Now: $0.18
$0.18
50-Day Range
$0.15
MA: $0.17
$0.20
52-Week Range
$0.07
Now: $0.18
$0.29
Volume646,264 shs
Average Volume450,624 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

MarketRank

Overall MarketRank

0.42 out of 5 stars

Energy Minerals Sector

27th out of 31 stocks

Oil & Gas Production Industry

27th out of 31 stocks

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Oil & Gas Production
Sub-IndustryN/A
Current SymbolOTCMKTS:EMHTF
CUSIPN/A
CIKN/A
Phone(800) 757-3536
Employees161
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
$0.18
0.00 (0.00 %)
(As of 01/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EMHTF News and Ratings via Email

Sign-up to receive the latest news and ratings for EMHTF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Emerald Health Therapeutics (OTCMKTS:EMHTF) Frequently Asked Questions

How has Emerald Health Therapeutics' stock price been impacted by COVID-19?

Emerald Health Therapeutics' stock was trading at $0.1450 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, EMHTF shares have increased by 21.4% and is now trading at $0.1760.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Emerald Health Therapeutics?

Wall Street analysts have given Emerald Health Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Emerald Health Therapeutics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Emerald Health Therapeutics' key competitors?

Who are Emerald Health Therapeutics' key executives?

Emerald Health Therapeutics' management team includes the following people:
  • Dr. Avtar S. Dhillon, Exec. Chairman (Age 59)
  • Mr. Riaz Bandali M.B.A., CEO & Pres (Age 50)
  • Ms. Jenn Hepburn B.B.A., CFO & Company Sec.
  • Mr. Bernie Hertel, VP of Fin. and Communications

What is Emerald Health Therapeutics' stock symbol?

Emerald Health Therapeutics trades on the OTCMKTS under the ticker symbol "EMHTF."

How do I buy shares of Emerald Health Therapeutics?

Shares of EMHTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Emerald Health Therapeutics' stock price today?

One share of EMHTF stock can currently be purchased for approximately $0.18.

What is Emerald Health Therapeutics' official website?

The official website for Emerald Health Therapeutics is www.emerald.care.

How can I contact Emerald Health Therapeutics?

The company can be reached via phone at (800) 757-3536.

This page was last updated on 1/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.